[Therapy of herpes simplex encephalitis].
Prange
H W
HW
Neurologische Klinik, Universität Göttingen.
D000212:Acyclovir / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D001929:Brain Edema / Q000188:drug therapy / Q000209:etiology; D001973:Bromodeoxyuridine / Q000031:analogs & derivatives / Q000627:therapeutic use; D003907:Dexamethasone / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D004660:Encephalitis / Q000150:complications / Q000188:drug therapy* / Q000209:etiology; D015774:Ganciclovir; D006561:Herpes Simplex / Q000188:drug therapy*; D006801:Humans; D007136:Immunoglobulins / Q000008:administration & dosage; D007372:Interferons / Q000627:therapeutic use; D014740:Vidarabine / Q000008:administration & dosage / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000998:Antiviral Agents; D007136:Immunoglobulins; C020235:brivudine; D003907:Dexamethasone; D007372:Interferons; D014740:Vidarabine; D001973:Bromodeoxyuridine; D015774:Ganciclovir; D000212:Acyclovir
Therapie der Herpes-simplex-Enzephalitis.